Related references
Note: Only part of the references are listed.
Review
Virology
Hanyan Meng et al.
Summary: It is necessary to implement a booster vaccination strategy for COVID-19 based on existing data. However, not all individuals require an additional dose of vaccine six months after the initial immunization. Priority should be given to high-risk groups such as the elderly and immunocompromised individuals. Heterologous boosters can induce stronger immune responses and enhance immune protection, but further scientific data and clinical studies are needed to verify safety.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Virology
Xiucai Zhang et al.
Summary: The global COVID-19 pandemic poses a serious threat to human life and health, emphasizing the importance of prompt laboratory diagnosis and source isolation. Choosing appropriate detection techniques can improve efficiency in disease diagnosis and treatment, aiding in the containment of infectious disease outbreaks.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Virology
Qing Ye et al.
Summary: The rapid spread of COVID-19 caused by SARS-CoV-2 has posed a severe threat to public life and health worldwide. Due to the long turnaround time and high cost of laboratory-based nucleic acid detection methods, there is an urgent need to develop convenient methods for detecting COVID-19. This paper summarizes the development of point-of-care testing (POCT) for novel coronavirus, focusing on nucleic acid extraction, nucleic acid amplification, and detection methods. It introduces a commercial real-time detection system that integrates these steps and provides important considerations for its use.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Virology
Dandan Tian et al.
Summary: During the COVID-19 pandemic, various variants of SARS-CoV-2 have emerged, showing increased infectivity and immune escape, posing new challenges to epidemic prevention and control.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Virology
Dandan Tian et al.
Summary: The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Botswana in November 2021 and has since become the dominant strain in many countries. With a high number of mutations, it presents new challenges for preventing and controlling COVID-19. This review aims to provide a scientific reference by analyzing and summarizing the biological characteristics, epidemic features, immune escape, and vaccine reactivity of the Omicron variant.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Virology
Xiucui Han et al.
Summary: The COVID-19 pandemic has caused severe losses worldwide, leading to a focus on vaccine development. The discovery of new virus variants has posed challenges to vaccine effectiveness, but utilizing vaccines effectively remains crucial in epidemic prevention and control.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Immunology
Qing Ye et al.
Summary: This paper evaluates the performance of commercial SARS-CoV-2 nucleic acid POCT products and provides recommendations for their selection and use. It also suggests standardizing the use of these products based on total quality management and discusses future development directions for POCT products.
MICROBES AND INFECTION
(2022)
Article
Public, Environmental & Occupational Health
Carlos Barrera-Avalos et al.
Summary: This study evaluated the sensitivity and specificity of RAT (SD BIOSENSOR, South Korea) widely used for COVID-19 testing and diagnosis in Santiago of Chile, and found that it had a certain effectiveness in detecting the virus. However, it is important to be cautious of its potential impact from new viral variants.
FRONTIERS IN PUBLIC HEALTH
(2022)
Review
Virology
Qing Ye et al.
Summary: SARS-CoV-2 antigen detection is a supplementary method for COVID-19 diagnosis, which can meet clinical needs to some extent, but it has low sensitivity for asymptomatic individuals in low prevalence areas, leading to missed diagnoses, and there are differences in detection ability for different virus strains. Although the SARS-CoV-2 antigen assay has high reliability in excluding infection, it has a high false positive rate in low prevalence environments and needs to be confirmed by nucleic acid detection.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Editorial Material
Physiology
Qing Ye et al.
Review
Virology
Xiucui Han et al.
Summary: In addition to affecting the lungs, SARS-CoV-2 can also frequently damage the kidneys, mainly manifesting as kidney tubular injury and proteinuria. Diagnosis and treatment of kidney complications should be strengthened to reduce patient mortality.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Public, Environmental & Occupational Health
Ian W. Pray et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2021)
Article
Infectious Diseases
Eliseo Albert et al.
Summary: The Panbio (TM) COVID-19 Ag Rapid Test Device performed well as a POC test for early diagnosis of COVID-19 in primary healthcare centres, with a specificity and sensitivity of 100% and 79.6% respectively. The negative predictive value of RAD was 99% and 97.9% under estimated prevalence of 5% and 10% respectively.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Microbiology
Nkemakonam C. Okoye et al.
Summary: The performance of Abbott BinaxNOW COVID-19 antigen card was compared to a standard RT-PCR assay for detecting SARS-CoV-2 in asymptomatic students. Results showed lower sensitivity but higher specificity for BinaxNOW compared to RT-PCR, indicating caution is needed when using rapid antigen testing for screening asymptomatic individuals.
JOURNAL OF CLINICAL MICROBIOLOGY
(2021)
Review
Virology
Qing Ye et al.
Summary: The false-positive detection of SARS-CoV-2 antibodies in clinical practice is mainly caused by endogenous interference factors like rheumatoid factor and heterophile antibodies, as well as exogenous interference factors including incomplete coagulation of the specimen and contamination of the specimen. These interferences can lead to confusion in the clinical diagnosis of COVID-19.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Review
Immunology
Dandan Tian et al.
Summary: The Delta variant of the SARS-CoV-2 virus, first reported in India in October 2020 and classified as a variant of concern by the WHO in May 2021, is highly transmissible and associated with increased hospitalization, ICU admission, and mortality rates. It has become the dominant strain in many countries globally.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Infectious Diseases
Kazuhiro Itoh et al.
Summary: In Japan, rapid antigen detection (RAD) test kits for severe acute respiratory syndrome coronavirus 2 are widely used as primary screening tests, but cases of false-positive results in a ward for patients with disabilities have raised concerns about potential hospital operational risks. Therefore, it is recommended to perform PCR tests appropriately instead of RAD tests for patients admitted to medical treatment wards with COVID-19 symptoms.
JOURNAL OF INFECTION AND CHEMOTHERAPY
(2021)
Review
Immunology
Xi Zhou et al.
Summary: The severity of COVID-19 is mainly related to host factors, especially cellular immune responses in patients. Treatment recommendations are tailored based on the dynamics of immune responses, including administering appropriate medications at different stages.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Medical Laboratory Technology
Xiucui Han et al.
Summary: This article summarizes the efforts made by various countries to deal with COVID-19, discusses the development and application of COVID-19 vaccines, and highlights the issues that need attention in vaccine development.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2021)
Article
Virology
Thomas Ferte et al.
Summary: This study evaluated the performance of antigenic tests (AT) for SARS-CoV-2 diagnosis, finding low sensitivity of AT in asymptomatic subjects but excellent specificity. The results indicate limitations in using AT in the general population, especially in asymptomatic individuals.
JOURNAL OF CLINICAL VIROLOGY
(2021)
Review
Medicine, General & Internal
Jacqueline Dinnes et al.
Summary: Accurate and rapid diagnostic tests for SARS-CoV-2 infection are crucial for managing the COVID-19 pandemic. Point-of-care antigen and molecular tests can increase access to testing and expedite clinical and public health management decisions. Studies show that antigen tests have varying sensitivity, with higher accuracy in the first week of infection, and the efficacy of molecular tests depends on the specific brand used.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(2021)
Review
Biochemistry & Molecular Biology
Zheng Chen et al.
Summary: Ongoing research has shown that asymptomatic SARS-CoV-2 infection is widespread in COVID-19 populations, with potential infectivity even before symptoms appear. Identifying asymptomatic infected individuals through nucleic acid testing is crucial in preventing disease spread, and China's successful prevention and control measures, like the "Four Early" policy, serve as a valuable model for other countries to follow.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2021)
Review
Virology
Qing Ye et al.
JOURNAL OF MEDICAL VIROLOGY
(2020)
Review
Virology
Dandan Tian et al.
JOURNAL OF MEDICAL VIROLOGY
(2020)
Review
Gastroenterology & Hepatology
Qing Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
(2020)
Review
Infectious Diseases
Qing Ye et al.
JOURNAL OF INFECTION
(2020)
Review
Cardiac & Cardiovascular Systems
Qing Ye et al.
